Anti HBc IgG Test at Ayzal Lab

Book at Ayzal Lab · Lahore

Book this test

Ayzal Lab logo

Ayzal Lab

30% off
Rs. 1,750Rs. 2,500

Anti HBc IgG Test at Ayzal Lab

The Anti-HBc IgG (Hepatitis B Core Antibody, IgG) test is a highly specific, clinically significant laboratory investigation used to detect previous or chronic exposure to the Hepatitis B Virus (HBV). Unlike other serological markers that may appear after vaccination, the presence of Anti-HBc IgG antibodies indicates a direct immunological response to the actual viral core antigen, signifying a natural infection. This laboratory test plays a fundamental role in clinical hepatology, gastroenterology, and infectious disease diagnostics by helping clinicians differentiate between active, chronic, resolved, or vaccine-induced immunity. At Ayzal Lab in Lahore, Pakistan, this assay is performed using advanced chemiluminescent immunoassay (CLIA) technology, ensuring exceptional analytical sensitivity and specificity for accurate patient profiling.

Understanding HBV serology is crucial for effective patient management. The Hepatitis B virus consists of several antigenic components, including the surface antigen (HBsAg) and the core antigen (HBcAg). While the core antigen itself does not circulate freely in the blood and cannot be directly measured, the human immune system produces specific antibodies against it. The total anti-HBc antibody response consists of both IgM and IgG classes. The IgM class is a marker of acute or highly active infection, whereas the IgG class persists for life, serving as a permanent immunological footprint of HBV exposure. Consequently, the Anti-HBc IgG test is indispensable for screening blood donors, evaluating patients with unexplained liver enzyme elevations, and assessing individuals before they undergo immunosuppressive therapy or chemotherapy, which could potentially reactivate a latent HBV infection.

By choosing Ayzal Lab, patients in Lahore receive high-quality diagnostic services backed by modern laboratory infrastructure. The test is performed on automated platforms that minimize human error and optimize turnaround times. Identifying a past exposure to Hepatitis B through this test allows healthcare providers to make informed decisions regarding vaccination, monitoring, and antiviral treatment, ultimately protecting the patient’s long-term liver health and preventing complications such as chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma.

Clinical Procedure: What to Expect

Patient Preparation

To ensure the highest level of analytical accuracy, patients undergoing the Anti-HBc IgG test at Ayzal Lab are advised to follow these preparation guidelines:

  • No Fasting Required: Fasting is generally not mandatory for the Anti-HBc IgG test. Patients can eat and drink normally prior to specimen collection.
  • Medication Disclosure: Inform the laboratory staff and your referring physician about all prescription medications, over-the-counter drugs, and dietary supplements you are currently taking. High doses of biotin (Vitamin B7) can interfere with certain immunoassay methodologies.
  • Hydration: Staying well-hydrated is recommended as it makes the veins more accessible, facilitating a smoother venipuncture process.
  • Wear Comfortable Clothing: Wear a shirt with sleeves that can be easily rolled up above the elbow to allow clear access to the venipuncture site.

During the Procedure

The collection of the blood specimen is a standard, safe, and routine process conducted by qualified phlebotomists at Ayzal Lab:

  • Patient Identification: The phlebotomist will verify your identity using your test requisition form and national identity details to ensure correct labeling.
  • Site Selection: The patient is seated comfortably, and the phlebotomist inspects the antecubital fossa (the crook of the elbow) to locate a suitable, prominent vein.
  • Sanitization: The selected area is thoroughly cleansed with an antiseptic swab (typically 70% isopropyl alcohol) and allowed to air dry to prevent specimen contamination.
  • Venipuncture: A sterile, single-use needle is gently inserted into the vein. A vacuum collection tube (typically a gold-top serum separator tube or red-top tube) is attached to collect the required volume of blood (approximately 3 to 5 mL).
  • Needle Removal and Care: Once the sample is collected, the needle is withdrawn, and gentle pressure is applied to the puncture site with a sterile cotton ball to stop any minor bleeding. A small adhesive bandage is then applied.
  • Specimen Processing: The collected blood tube is labeled immediately at the patient’s side, allowed to clot, and centrifuged to separate the serum. The serum is then analyzed using automated immunoassay systems.

When is an Anti HBc IgG Test Performed?

Screening for Chronic Hepatitis B Infection

Physicians frequently request the Anti-HBc IgG test as part of a comprehensive Hepatitis B panel when evaluating patients suspected of having chronic HBV. Chronic hepatitis B often presents with non-specific symptoms such as mild fatigue, abdominal discomfort, or may remain completely asymptomatic for decades. This test helps identify individuals who have been exposed to the virus in the past and continue to carry it, allowing for early therapeutic intervention and regular monitoring of liver function.

Differentiating Vaccine-Induced Immunity from Natural Infection

It is clinically vital to distinguish whether a patient’s immunity to Hepatitis B is the result of successful vaccination or a cleared natural infection. Individuals who have been vaccinated against HBV will test positive for anti-HBs (surface antibodies) but negative for Anti-HBc IgG, as the vaccine only contains the surface antigen. Conversely, those who have recovered from a natural infection will test positive for both anti-HBs and Anti-HBc IgG. This distinction guides clinicians on whether booster doses of the vaccine are necessary.

Pre-Immunosuppression and Pre-Chemotherapy Screening

Before initiating chemotherapy, biological therapies, or potent immunosuppressive regimens (such as those used for autoimmune diseases or organ transplantation), patients must be screened for latent HBV. Immunosuppression can lead to the reactivation of a dormant Hepatitis B virus, resulting in severe, life-threatening acute liver failure. A positive Anti-HBc IgG test alerts the oncologist or rheumatologist to initiate prophylactic antiviral therapy to prevent viral replication during treatment.

Investigation of Unexplained Liver Enzyme Elevations

When routine blood panels reveal elevated levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST), indicating liver inflammation or damage, the primary care physician must investigate the underlying cause. The Anti-HBc IgG test is included in the diagnostic workup to rule out or confirm chronic viral hepatitis as the source of hepatic injury, helping to prevent the silent progression toward liver fibrosis.

Screening of Blood, Tissue, and Organ Donors

To ensure the safety of the blood supply and transplant recipients, all potential blood, tissue, and organ donors are rigorously screened for infectious diseases. The Anti-HBc IgG test is a standard screening protocol to detect any previous exposure to HBV, minimizing the risk of transfusion-transmitted or transplant-transmitted viral infections to vulnerable recipients.

What Does an Anti HBc IgG Test Detect?

The Anti-HBc IgG test is designed to detect specific immunoglobulin G antibodies directed against the core antigen of the Hepatitis B virus. The clinical findings and interpretations associated with this test include:

  • Detection of Past Resolved Infection: Identifies patients who contracted HBV in the past, successfully cleared the virus naturally, and developed protective immunity.
  • Detection of Active Chronic Infection: When found in conjunction with a positive HBsAg, it confirms a long-standing, active chronic Hepatitis B infection.
  • Identification of Occult Hepatitis B: Detects potential low-level viral persistence in patients who are HBsAg-negative but possess detectable HBV DNA.
  • Exclusion of Vaccine-Induced Immunity: A negative Anti-HBc IgG result in a patient with positive anti-HBs confirms that their immunity is solely due to vaccination.
  • Assessment of Exposure Risk: Evaluates whether an individual has ever come into contact with the wild-type Hepatitis B virus.
  • Latent Viral Persistence: Signals the presence of viral covalently closed circular DNA (cccDNA) in the hepatocytes, which remains dormant but capable of reactivation.
  • Differential Diagnosis of Acute vs. Chronic Hepatitis: Helps differentiate chronic infection (IgG positive, IgM negative) from acute infection (IgM positive).
  • Maternal-Fetal Transmission Risk: Assesses pregnant individuals for past exposure, guiding neonatal prophylaxis protocols.

Turnaround Time and Report Access at Ayzal Lab

At Ayzal Lab, we understand that timely diagnostic results are critical for clinical decision-making and patient peace of mind. The Anti-HBc IgG test is processed daily using high-throughput, automated immunoassay analyzers. Under standard operating procedures, the final verified report is typically available within 12 to 24 hours from the time of sample collection. Patients are notified via SMS once their results are ready. Reports can be securely accessed and downloaded online through the official Ayzal Lab web portal or patient application, or collected in person from our diagnostic center in Lahore.

Anti HBc IgG Findings Overview

Structure / Parameter Evaluated Normal Findings Possible Abnormal Findings
Anti-HBc IgG / Total Anti-HBc Negative (Non-reactive) Positive (Reactive)
HBsAg Co-evaluation Negative Positive (Indicates active chronic infection)
Anti-HBs Co-evaluation Positive (If vaccinated or recovered) Negative (In chronic carriers or non-immune)
Anti-HBc IgM Co-evaluation Negative Positive (Indicates acute or recent infection)
HBV DNA (Viral Load) Undetectable Detectable (Indicates active viral replication)
Liver Enzymes (ALT/AST) Within normal reference range Elevated (Indicates active hepatic inflammation)
Clinical Status Interpretation No prior natural exposure to HBV Prior exposure, chronic carrier, or resolved infection

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Ayzal Lab for Anti HBc IgG?

  • Experienced Healthcare Professionals: Our laboratory is staffed by highly qualified pathologists and technologists specializing in clinical chemistry and serology.
  • Patient-Focused Care: We prioritize patient comfort, safety, and confidentiality throughout the testing process.
  • Quality Diagnostic Services: Ayzal Lab adheres to strict internal and external quality control protocols to ensure clinical accuracy.
  • Professional Reporting: Clear, comprehensive, and easy-to-understand reports designed to assist clinicians in rapid diagnosis.
  • Modern Diagnostic Approach: Utilizing state-of-the-art automated immunoassay systems for precise molecular and serological testing.
  • Comfortable Environment: A clean, hygienic, and welcoming environment designed to make your diagnostic visit stress-free.
  • Convenient Location: Easily accessible diagnostic facility located in Lahore, Pakistan, offering flexible walk-in services.
  • Commitment to Accurate Diagnosis: Dedicated to delivering reliable, evidence-based diagnostic insights to support your healthcare journey.

Frequently Asked Questions